Absci ABSI
NASDAQ ABSI
$11.10 +0.93 (+9.14%)
As of: Nov 9, 2026 · 10:53 AM EST

Absci (ABSI) Return on Sales [ROS] (2020 - 2026)

Updated

Absci (ABSI) recorded Return on Sales [ROS] of -10741.51% in Q2 2026, down 5447.58 percentage points from -5293.93% a year earlier but up 3605.47 percentage points from the prior quarter.

Analysis

Absci (ABSI) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

On a TTM basis, Absci's Return on Sales [ROS] came in at -8084.50% as of Jun 30, 2026, down 5237.93 percentage points year-over-year; for FY2025, it came in at -4297.04%, down 1895.45 percentage points from FY2024.

  • Annual Return on Sales [ROS] has declined for five straight years, with a five-year change of -4018.77 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -2401.59% in FY2024 (-381.39 pp), -2020.20% in FY2023 (-162.71 pp), -1857.49% in FY2022 (-284.13 pp) and -1573.36% in FY2021 (-1295.09 pp).
  • Quarterly Return on Sales [ROS] has ranged from -14346.98% in Q1 2026 to -1180.54% in Q3 2022 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] has declined for five consecutive quarters, with an average year-over-year change of -2833.65 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 2841.94 percentage points in Q4 2024, against a drop of 11995.07 percentage points in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -14346.98% (Q1 2026), -4775.54% (Q4 2025) and -7977.25% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,249.15 Bn 1,222.76 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 672.28 Bn 592.14 Bn 17.30 Bn 24.35%
3 AbbVie 515.12 Bn 483.13 Bn 13.12 Bn 36.01%
4 Merck 364.35 Bn 327.29 Bn 13.19 Bn 30.89%
5 Novartis Ag 315.18 Bn 288.42 Bn - -
6 Astrazeneca 292.81 Bn 266.70 Bn 13.26 Bn 29.12%
7 Amgen 249.17 Bn 200.82 Bn 7.58 Bn 35.79%
8 Gilead Sciences 210.23 Bn 185.34 Bn 6.73 Bn 41.71%
9 Pfizer 165.64 Bn 113.00 Bn 12.56 Bn 32.98%
10 Absci 1.76 Bn 1.13 Bn - -10,741.51%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10,741.51%
Mar 31, 2026 -14,346.98%
Dec 31, 2025 -4,775.54%
Sep 30, 2025 -7,977.25%
Jun 30, 2025 -5,293.93%
Mar 31, 2025 -2,351.91%
Dec 31, 2024 -4,477.29%
Sep 30, 2024 -1,698.71%
Jun 30, 2024 -2,104.02%
Mar 31, 2024 -2,616.70%
Dec 31, 2023 -7,319.23%
Sep 30, 2023 -3,132.12%
Jun 30, 2023 -1,276.74%
Mar 31, 2023 -1,929.47%
Dec 31, 2022 -1,354.72%
Sep 30, 2022 -1,180.54%
Jun 30, 2022 -2,882.93%
Mar 31, 2022 -3,516.85%
Dec 31, 2021 -1,808.26%
Sep 30, 2021 -1,373.75%
API Access

Absci Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABSI&period=max&api_key=YOUR_API_KEY